Dr Martens, a renowned boot manufacturer, anticipates a substantial financial impact from US tariffs this year. The company is expecting a multimillion-pound blow due to increased import duties affecting its footwear production in Vietnam as a result of the trade war instigated by US President Donald Trump.
To mitigate the adverse effects of tariffs, Dr Martens has restructured its supply chain, reducing its reliance on China for production to avoid higher US import tariffs. Despite the tariff challenges, the company remains confident in meeting its full-year profit forecasts of between £53 million to £60 million in underlying pre-tax profits.
However, the news of the tariff impact caused a sharp decline in Dr Martens’ share price, dropping by over 10% during early trading. The company, known for its iconic yellow-stitched boots, plans to fully counter the additional tariff costs starting next year through stringent cost control, product sourcing flexibility, and adjustments in pricing strategies for the US market.
The latest update on tariffs coincided with the release of half-year financial results, showing a reduction in losses to £11 million for the six months ending September 28, compared to £12.3 million in the previous year. Despite the challenges, Dr Martens reported a modest 0.8% increase in sales, reaching £327.3 million in the first half.
Ije Nwokorie, the CEO of Dr Martens, expressed optimism about the company’s performance, highlighting a significant rise in shoe volumes and successful product launches. While acknowledging market uncertainties and consumer caution, Nwokorie emphasized confidence in the company’s strategies for the year ahead.
Russ Mould, investment director at broker AJ Bell, noted Dr Martens’ incremental progress towards profitability but cautioned that the recovery process might be gradual. While there were positive signs in the half-year results, such as improved product pricing and a stronger performance in the Americas region, investor reaction remained subdued, with the share price declining in early trading.